Posts Tagged ‘ABUS’

Inspired by an Ancient Queen

Posted on: May 20th, 2022 by admin

A decade ago, Siddhartha Mukherjee published his prize-winning book entitled The Emperor of All Maladies: A Biography of Cancer. He quoted from […]

Another US Patent for CapeRay

Posted on: April 22nd, 2022 by admin 3 Comments

Five years ago, we reported that the United States Patent and Trademark Office (USPTO) had awarded CapeRay a key patent to protect our novel dual-modality […]

AI for Breast Ultrasound

Posted on: April 8th, 2022 by admin

On 23 December 2021, the board of directors of RSNA announced that Dr Linda Moy (seen right) would become editor of their […]

ABUS and DBT and FFDM

Posted on: March 18th, 2022 by admin 2 Comments

It was five years ago that we published a key article in Diagnostics, an open-access journal, in which we described our dual-modality […]

Understanding Breast Density

Posted on: January 28th, 2022 by admin 2 Comments

The Merriam-Webster dictionary provides three essential meanings for the word “density”: having parts that are close together; being difficult to see through; […]

Ultrasound to the Fore

Posted on: January 14th, 2022 by admin

The online magazine AuntMinnie.com has just published a review article by Emily Hayes entitled “Ultrasound jostles for bigger role in screening dense breasts.” With […]

Evaluating DBT after 10 Years

Posted on: December 3rd, 2021 by admin

Earlier this year, we described how the digital breast tomosynthesis (DBT) pioneers, led by Dr Daniel Kopans, developed a screening tool that […]

Global Breast Imaging Report

Posted on: October 29th, 2021 by admin 4 Comments

Earlier this month, we drew attention to the fact that October is traditionally recognised as breast cancer awareness month. It’s therefore appropriate […]

Launch of RemotEye Suite

Posted on: September 3rd, 2021 by admin 1 Comment

NeoLogica, founded in 2002 by a small group of engineers, specializes in the design and development of advanced software solutions […]

Optimising Breast Cancer Screening

Posted on: August 27th, 2021 by admin

Six years ago, we reviewed a paper published in The Lancet by the Japan Strategic Anti-Cancer Randomized Trial (J-START) in which the […]